Logo

ErVaccine Technologies

EIC Accelerator Winner From 2023

Development of a cell immunotherapy targeting non-conventional tumor antigens in ovarian cancer

Visit Website
France

Articles

ErVaccine Technologies Secures EIC Accelerator Funding to Advance Innovative Cancer Therapies

FranceEIC Accelerator2023
Read Article
Back to All Companies

EIC Accelerator Deadline

00
Days
00
Hours
00
Minutes
00
Seconds

How Can We Help You Succeed?

AI Writer

Budget-friendly AI tools, templates and instructions

Advisory Service

Personalized support for teams with in-house writers

Full Writing

Full Writing of all Proposal Sections by Stephan Segler, PhD